Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk Variant (YOH1)
This study is enrolling participants by invitation only.
Sponsor:
Anders Rosengren, MD PhD
Collaborators:
Region Skane
Lund University
Information provided by (Responsible Party):
Anders Rosengren, MD PhD, Region Skane
ClinicalTrials.gov Identifier:
NCT01593215
First received: May 3, 2012
Last updated: August 21, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is enrolling participants by invitation only. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |